United States · FDA National Drug Code directory
VIDAZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59572-102_8cba79e2-11fa-4eb9-87e7-827ca781fbf3
- Product NDC
- 59572-102
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- azacitidine
- Labeler
- Celgene Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20040705
- Source listing expiry
- 20261231
Source-listed ingredients
- AZACITIDINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (59572-102-01) · 59572-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →